Body Mass Index and Risk of Post‑Treatment Relapse in Endometrial Cancer: Evidence from an Iraqi Cross‑Sectional Cohort

Authors
  • Zainab Mohamed Alaa Alhelli

    Sadr Oncology Center, Baghdad, Iraq
  • Amaal Mohammed Alhelli

    Department of Water Resource Technique, Institute of Technology, Middle Technical University, Alzafaranya, Baghdad 29008, Iraq
  • Aadil S Aqabi

    Medical City Blood Disease & Transplant Center, Baghdad, Iraq
Keywords:
Endometrial Cancer, Obesity, Body Mass Index, Relapse, Prognostic Marker
Abstract

Obesity has been identified as a contributing factor to the development and outcomes of endometrial cancer (EC), yet its role in post-treatment relapse remains to be elucidated. The objective of this study is to examine the association between body mass index (BMI) and the incidence of relapse among Iraqi women diagnosed with endometrial cancer (EC). A cross-sectional study was conducted at the Oncology Teaching Hospital, Baghdad Medical City (January–October 2021). A total of 75 women with histologically confirmed EC were categorized by BMI (normal weight, overweight, obese) according to the WHO criteria. Relapse was ascertained during routine follow-up and compared across BMI categories using chi-square testing. The discriminatory performance of continuous BMI was assessed using receiver operating characteristic (ROC) analysis. The results indicated that relapse occurred in 24% of normal-weight patients, 32% of overweight patients, and 60% of obese patients (χ² = 7.17; p = 0.027). The BMI exhibited moderate discriminatory capability for relapse (AUC=0.638; 95% CI 0.505–0.771; p=0.045), with an optimal threshold of 26.9 kg/m² (sensitivity 72%, specificity 48%). A higher BMI has been demonstrated to be associated with an increased risk of relapse following EC treatment. Given its modest discriminatory performance, BMI should not be considered a stand-alone prognostic marker. However, it may provide supportive information in low-resource settings. The validation of these findings in larger, multivariable studies is warranted.

References

Allott, E. H., & Hursting, S. D. (2015). Obesity and cancer: mechanistic insights from transdisciplinary studies. Endocrine-Related Cancer, 22(6), R365–R386. https://doi.org/10.1530/ERC-15-0400

Arem, H., & Irwin, M. L. (2013). Obesity and endometrial cancer survival: a systematic review. International Journal of Obesity, 37(5), 634–639. https://doi.org/10.1038/ijo.2012.94

Burkett, W. C., Clontz, A. D., Keku, T. O., & Bae-Jump, V. (2023). The interplay of obesity, microbiome dynamics, and innovative anti-obesity strategies in the context of endometrial cancer progression and therapeutic approaches. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, 1878(6), 189000. https://doi.org/10.1016/j.bbcan.2023.189000

Calle, E. E., Rodriguez, C., Walker-Thurmond, K., & Thun, M. J. (2003). Overweight, Obesity, and Mortality from Cancer in a Prospectively Studied Cohort of U.S. Adults. New England Journal of Medicine, 348(17), 1625–1638. https://doi.org/10.1056/NEJMoa021423

Clark, L. H., Ko, E. M., Kernodle, A., Harris, A., Moore, D. T., Gehrig, P. A., & Bae-Jump, V. (2016). Endometrial Cancer Survivors’ Perceptions of Provider Obesity Counseling and Attempted Behavior Change Are We Seizing the Moment? International Journal of Gynecological Cancer, 26(2), 318–324. https://doi.org/10.1097/IGC.0000000000000596

Deng, L., Feng, J., & Broaddus, R. R. (2010). The novel estrogen-induced gene EIG121 regulates autophagy and promotes cell survival under stress. Cell Death & Disease, 1(4), e32–e32. https://doi.org/10.1038/cddis.2010.9

Donkers, H., Fasmer, K. E., Mcgrane, J., Pijnenborg, J. M. A., Bekkers, R., Haldorsen, I. S., & Galaal, K. (2021). Obesity and visceral fat: Survival impact in high-grade endometrial cancer. European Journal of Obstetrics & Gynecology and Reproductive Biology, 256, 425–432. https://doi.org/10.1016/j.ejogrb.2020.11.050

Endometrial cancer report | World Cancer Research Fund. (n.d.). https://www.wcrf.org/research-policy/library/endometrial-cancer-report/

Harvey, S. V, Wentzensen, N., Bertrand, K., Black, A., Brinton, L. A., Chen, C., Costas, L., Dal Maso, L., De Vivo, I., Du, M., Garcia-Closas, M., Goodman, M. T., Gorzelitz, J., Johnson, L., Lacey, J. V, Liao, L., Lipworth, L., Lissowska, J., Miller, A. B., … Clarke, M. A. (2023). Associations of life course obesity with endometrial cancer in the Epidemiology of Endometrial Cancer Consortium (E2C2). International Journal of Epidemiology, 52(4), 1086–1099. https://doi.org/10.1093/ije/dyad046

Karataşlı, V., Can, B., Çakır, İ., Erkılınç, S., Kuru, O., Gökçü, M., & Sancı, M. (2021). Life quality of endometrioid endometrial cancer survivors: a cross-sectional study. Journal of Obstetrics and Gynaecology, 41(4), 621–625. https://doi.org/10.1080/01443615.2020.1787969

Koliaki, C., Dalamaga, M., & Liatis, S. (2023). Update on the Obesity Epidemic: After the Sudden Rise, Is the Upward Trajectory Beginning to Flatten? Current Obesity Reports, 12(4), 514–527. https://doi.org/10.1007/s13679-023-00527-y

Ladas, E. J., Sheng, H., Athale, U. H., Asselin, B. L., Clavell, L. A., Cole, P. D., Flamand, Y., Leclerc, J.-M., Laverdiere, C., Michon, B., Sallan, S. E., Silverman, L. B., Welch, J. J. G., Yao, S., & Kelly, K. M. (2025). Overweight or Obesity and Outcomes in Children With Acute Lymphoblastic Leukemia. JAMA Network Open, 8(5), e259952. https://doi.org/10.1001/jamanetworkopen.2025.9952

Lewin, S. N., Herzog, T. J., Medel, N. I. B., Deutsch, I., Burke, W. M., Sun, X., & Wright, J. D. (2010). Comparative Performance of the 2009 International Federation of Gynecology and Obstetricsʼ Staging System for Uterine Corpus Cancer. Obstetrics & Gynecology, 116(5), 1141–1149. https://doi.org/10.1097/AOG.0b013e3181f39849

Li, X., Yang, X., Cheng, Y., Dong, Y., Wang, J., & Wang, J. (2023). Development and validation of a prognostic model based on metabolic risk score to predict overall survival of endometrial cancer in Chinese patients. Journal of Gynecologic Oncology, 34(6). https://doi.org/10.3802/jgo.2023.34.e69

Makker, V., MacKay, H., Ray-Coquard, I., Levine, D. A., Westin, S. N., Aoki, D., & Oaknin, A. (2021). Endometrial cancer. Nature Reviews Disease Primers, 7(1), 88. https://doi.org/10.1038/s41572-021-00324-8

Marin, A.-G., Filipescu, A., & Petca, A. (2024). The Role of Obesity in the Etiology and Carcinogenesis of Endometrial Cancer. Cureus. https://doi.org/10.7759/cureus.59219

Mihm, M., Gangooly, S., & Muttukrishna, S. (2011). The normal menstrual cycle in women. Animal Reproduction Science, 124(3–4), 229–236. https://doi.org/10.1016/j.anireprosci.2010.08.030

Onstad, M. A., Schmandt, R. E., & Lu, K. H. (2016). Addressing the Role of Obesity in Endometrial Cancer Risk, Prevention, and Treatment. Journal of Clinical Oncology, 34(35), 4225–4230. https://doi.org/10.1200/JCO.2016.69.4638

Perry, R. J., & Shulman, G. I. (2020). Mechanistic Links between Obesity, Insulin, and Cancer. Trends in Cancer, 6(2), 75–78. https://doi.org/10.1016/j.trecan.2019.12.003

Reeves, G. K., Pirie, K., Beral, V., Green, J., Spencer, E., & Bull, D. (2007). Cancer incidence and mortality in relation to body mass index in the Million Women Study: cohort study. BMJ, 335(7630), 1134. https://doi.org/10.1136/bmj.39367.495995.AE

Renehan, A. G., Tyson, M., Egger, M., Heller, R. F., & Zwahlen, M. (2008). Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. The Lancet, 371(9612), 569–578. https://doi.org/10.1016/S0140-6736(08)60269-X

Simancas-Racines, D., Campuzano-Donoso, M., Román-Galeano, N. M., Zambrano-Villacres, R., Memoli, P., Verde, L., Reytor-González, C., & Carbone, L. (2025). Obesity and endometrial cancer: biological mechanisms, nutritional strategies, and clinical perspectives. Food and Agricultural Immunology, 36(1). https://doi.org/10.1080/09540105.2025.2510961

Von Gruenigen, V. E., Courneya, K. S., Gibbons, H. E., Kavanagh, M. B., Waggoner, S. E., & Lerner, E. (2008). Feasibility and effectiveness of a lifestyle intervention program in obese endometrial cancer patients: A randomized trial. Gynecologic Oncology, 109(1), 19–26. https://doi.org/10.1016/j.ygyno.2007.12.026

Cover Image
Downloads
Additional Files
Published
2025-10-18
Section
Research Article/Original Research
License

Copyright (c) 2025 Zainab Mohamed Alaa Alhelli, Amaal Mohammed Alhelli, Aadil S Aqabi

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

How to Cite

Alhelli, Z. M. A., Alhelli, A. M., & Aqabi, A. S. (2025). Body Mass Index and Risk of Post‑Treatment Relapse in Endometrial Cancer: Evidence from an Iraqi Cross‑Sectional Cohort. Middle Eastern Cancer and Oncology Journal, 1(4), 6-10. https://doi.org/10.61706/MECOJ160196